General Information of Drug (ID: DM8RY7G)

Drug Name
3-formyl-4-phenyl-1,2,5-oxadiazole 2-oxide
Synonyms
CHEMBL567637; 135733-34-5; 1,2,5-Oxadiazole-3-carboxaldehyde, 4-phenyl-, 2-oxide; 3-formyl-4-phenyl-1,2,5-oxadiazole n2-oxide; ACMC-20mvvi; 3-formyl-4-phenyl-1,2,5-oxadiazole 2-oxide; CTK0F4054; DTXSID00438521; 3-Formyl-4-phenylfurazan 2-oxide; BDBM50300756
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 190.16
Logarithm of the Partition Coefficient (xlogp) 1.5
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C9H6N2O3
IUPAC Name
2-oxido-4-phenyl-1,2,5-oxadiazol-2-ium-3-carbaldehyde
Canonical SMILES
C1=CC=C(C=C1)C2=NO[N+](=C2C=O)[O-]
InChI
InChI=1S/C9H6N2O3/c12-6-8-9(10-14-11(8)13)7-4-2-1-3-5-7/h1-6H
InChIKey
MNNADPGXJASGIU-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
10352496
CAS Number
135733-34-5
TTD ID
D05ABT

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cytoplasmic thioredoxin reductase (TXNRD1) TTR7UJ3 TRXR1_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schis... J Med Chem. 2009 Oct 22;52(20):6474-83.